» Articles » PMID: 26528494

Low Risk of Bacteremia After Endoscopic Variceal Therapy for Esophageal Varices: a Systematic Review and Meta-analysis

Overview
Journal Endosc Int Open
Specialty Gastroenterology
Date 2015 Nov 4
PMID 26528494
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Study Aims: Endoscopic variceal ligation (EVL) and endoscopic variceal sclerotherapy (EVS) are the main therapeutic procedures for the emergency treatment and secondary prophylaxis of esophageal varices in cirrhotics. Post-endoscopic bacteremia has been reported after EVS and EVL, but data on the frequency of bacteremia are conflicting. This study aims to provide incidences of bacteremia after EVS and EVL in different settings through meta-analysis.

Methods: Only prospective or randomized studies were included in this meta-analysis. Binomial distribution was used to compute variance for each study. Random effects models were used as the final model for estimating the effect size and 95 % confidence interval. Adjusted effects were obtained using meta-regression analysis.

Results: Nineteen prospective studies involving 1001 procedures in 587 patients were included in the meta-analysis on the risk of bacteremia after EVS or EVL in cirrhotics with esophageal varices. The frequency of bacteremia after endoscopic variceal therapy was 13 %. The frequency of bacteremia after EVS (17 %) was higher than after EVL (6 %) with no statistically significant difference (P = 0.106). The frequency of bacteremia after elective EVS (14 %) was significantly less than after emergency EVS (22 %) (P < 0.001). The frequency of bacteremia after elective EVL (7.6 %) was not significantly different from after emergency EVL (3.2 %) (P = 0.850).

Conclusions: The incidence of bacteremia is low in patients with cirrhosis and varices after esophageal variceal therapy. These results are consistent with our current guidelines that antibiotic prophylaxis before endoscopic variceal therapy is only necessary for bleeding patients.

Citing Articles

Antibiotic prophylaxis vs. on‑demand antibiotic treatment in endoscopic therapy for variceal hemorrhage: A meta‑analysis of randomized controlled trials.

Tao Z, Pu W, Guo Y, Zhang Y, Tang X, Hou Y Exp Ther Med. 2024; 28(3):340.

PMID: 39006450 PMC: 11240267. DOI: 10.3892/etm.2024.12629.


Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice.

Ferrarese A, Passigato N, Cusumano C, Gemini S, Tonon A, Dajti E World J Hepatol. 2021; 13(8):840-852.

PMID: 34552691 PMC: 8422913. DOI: 10.4254/wjh.v13.i8.840.


A Prospective Randomized Study on the Risk of Bacteremia in Banding versus Sclerotherapy of Esophageal Varices.

Zuckerman M, Jia Y, Hernandez J, Kolli V, Norte A, Amin H Front Med (Lausanne). 2016; 3:16.

PMID: 27200352 PMC: 4852182. DOI: 10.3389/fmed.2016.00016.

References
1.
Hegnhoj J, Andersen J, Jarlov J, Bendtsen F, Rasmussen H . Bacteriaemia after injection sclerotherapy of oesophageal varices. Liver. 1988; 8(3):167-71. DOI: 10.1111/j.1600-0676.1988.tb00986.x. View

2.
Banerjee S, Shen B, Baron T, Nelson D, Anderson M, Cash B . Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008; 67(6):791-8. DOI: 10.1016/j.gie.2008.02.068. View

3.
Qureshi W, Adler D, Davila R, Egan J, Hirota W, Leighton J . ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc. 2005; 62(5):651-5. DOI: 10.1016/j.gie.2005.07.031. View

4.
Rolando N, Gimson A, Philpott-Howard J, Sahathevan M, Casewell M, Fagan E . Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. J Hepatol. 1993; 18(3):290-4. DOI: 10.1016/s0168-8278(05)80272-7. View

5.
Camara D, Gruber M, Barde C, Montes M, Caruana Jr J, Chung R . Transient bacteremia following endoscopic injection sclerotherapy of esophageal varices. Arch Intern Med. 1983; 143(7):1350-2. View